| Code | Description | Claims | Beneficiaries | Total Paid |
| T1015 |
Clinic visit/encounter, all-inclusive |
104,518 |
93,843 |
$9.01M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
2,368 |
2,367 |
$1.38M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
81,592 |
74,462 |
$746K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
28,843 |
27,101 |
$578K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
10,398 |
10,340 |
$469K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
5,935 |
5,916 |
$342K |
| 64615 |
|
2,307 |
2,289 |
$187K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
2,039 |
2,035 |
$157K |
| 95886 |
|
2,012 |
1,008 |
$135K |
| 99215 |
Prolong outpt/office vis |
1,409 |
1,369 |
$102K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
4,616 |
4,322 |
$100K |
| 59425 |
|
1,346 |
842 |
$99K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
31,650 |
28,451 |
$79K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
19,557 |
16,430 |
$69K |
| 90686 |
|
6,199 |
6,191 |
$67K |
| 99406 |
|
8,898 |
8,069 |
$67K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,065 |
1,056 |
$60K |
| 90715 |
|
1,747 |
1,743 |
$49K |
| 25600 |
|
236 |
233 |
$48K |
| 90750 |
|
388 |
386 |
$47K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,036 |
1,035 |
$46K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,424 |
1,414 |
$45K |
| 20553 |
|
783 |
771 |
$41K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
528 |
526 |
$40K |
| 76942 |
|
1,786 |
894 |
$38K |
| 99245 |
|
244 |
243 |
$29K |
| 29075 |
|
332 |
327 |
$29K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,635 |
1,492 |
$28K |
| 73610 |
|
1,092 |
1,011 |
$23K |
| 99243 |
|
305 |
305 |
$23K |
| 92551 |
|
3,724 |
3,707 |
$19K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
730 |
722 |
$18K |
| 90677 |
|
187 |
186 |
$17K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,042 |
5,957 |
$17K |
| 73620 |
|
1,116 |
1,042 |
$15K |
| 73110 |
|
773 |
706 |
$15K |
| 90651 |
|
445 |
443 |
$14K |
| 95911 |
|
98 |
49 |
$12K |
| 90678 |
|
33 |
33 |
$11K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
1,014 |
988 |
$11K |
| 90670 |
|
668 |
662 |
$10K |
| 95908 |
|
178 |
89 |
$10K |
| 73630 |
|
441 |
412 |
$9K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
196 |
196 |
$9K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
906 |
891 |
$9K |
| 0064A |
|
162 |
108 |
$9K |
| 73100 |
|
560 |
489 |
$9K |
| 92250 |
|
153 |
153 |
$8K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
52 |
50 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
413 |
410 |
$8K |
| 77080 |
|
199 |
163 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
206 |
205 |
$6K |
| 81025 |
|
1,961 |
1,895 |
$6K |
| 82274 |
|
347 |
347 |
$6K |
| 90682 |
|
130 |
130 |
$6K |
| 20610 |
|
146 |
109 |
$6K |
| 90746 |
|
189 |
189 |
$6K |
| 90734 |
|
361 |
361 |
$6K |
| 95910 |
|
50 |
25 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
608 |
601 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
155 |
145 |
$5K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
347 |
346 |
$5K |
| 90732 |
|
87 |
87 |
$5K |
| 73590 |
|
239 |
219 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
269 |
267 |
$4K |
| 95885 |
|
78 |
41 |
$4K |
| 0124A |
|
58 |
58 |
$4K |
| 73562 |
|
185 |
175 |
$4K |
| 17110 |
|
39 |
38 |
$4K |
| 73080 |
|
147 |
137 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
554 |
472 |
$3K |
| 0001A |
|
58 |
30 |
$3K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
108 |
102 |
$3K |
| 81002 |
|
5,947 |
5,144 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
44 |
42 |
$3K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
262 |
260 |
$3K |
| 95909 |
|
32 |
16 |
$2K |
| 73090 |
|
130 |
107 |
$2K |
| 73130 |
|
105 |
101 |
$2K |
| 86580 |
|
626 |
594 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
348 |
339 |
$2K |
| 90662 |
|
297 |
297 |
$2K |
| 73030 |
|
90 |
87 |
$2K |
| 77081 |
|
105 |
82 |
$2K |
| 90480 |
|
54 |
54 |
$2K |
| 0012A |
|
30 |
17 |
$2K |
| 90685 |
|
250 |
250 |
$2K |
| 0969 |
|
25 |
14 |
$1K |
| 0002A |
|
27 |
14 |
$1K |
| 96127 |
|
317 |
312 |
$1K |
| 0004A |
|
24 |
12 |
$1K |
| 99173 |
|
1,688 |
1,680 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
96 |
93 |
$1K |
| 73070 |
|
47 |
38 |
$896.85 |
| 90698 |
|
90 |
89 |
$883.53 |
| 72170 |
|
39 |
39 |
$859.20 |
| 73000 |
|
45 |
43 |
$829.06 |
| 72100 |
|
40 |
40 |
$768.17 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
203 |
193 |
$758.66 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
80 |
80 |
$747.14 |
| G0466 |
Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
165 |
165 |
$680.80 |
| 69209 |
|
73 |
65 |
$667.46 |
| H1003 |
Prenatal care, at-risk enhanced service; education |
49 |
38 |
$641.59 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
219 |
217 |
$589.58 |
| 90633 |
|
63 |
63 |
$567.00 |
| 90680 |
|
54 |
53 |
$486.00 |
| J3490 |
Unclassified drugs |
15 |
15 |
$399.00 |
| 0761 |
|
13 |
13 |
$374.33 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
113 |
112 |
$332.49 |
| 99442 |
|
12 |
12 |
$295.20 |
| 99188 |
|
13 |
13 |
$280.80 |
| 99441 |
|
14 |
14 |
$239.83 |
| 73140 |
|
27 |
27 |
$215.60 |
| 82948 |
|
228 |
223 |
$199.73 |
| 90744 |
|
29 |
29 |
$153.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
94 |
94 |
$5.35 |
| A4649 |
Surgical supply; miscellaneous |
153 |
149 |
$3.02 |
| 90837 |
Psychotherapy, 53 minutes with patient |
421 |
267 |
$0.00 |
| 91322 |
|
27 |
27 |
$0.00 |
| 90656 |
|
239 |
239 |
$0.00 |
| Z1034 |
|
913 |
584 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
13 |
13 |
$0.00 |
| 0270 |
|
26 |
25 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
34 |
34 |
$0.00 |
| Z7610 |
|
38 |
37 |
$0.00 |
| 0636 |
|
15 |
12 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
104 |
102 |
$0.00 |